Abstract
Etanercept-induced organizing pneumonia (OP) has not been reported in Japan. We describe the case of a rheumatoid arthritis patient who developed OP during etanercept treatment and discuss the possible mechanisms underlying the development of etanercept-induced OP and the existence of factors that predispose Japanese patients to drug-induced OP.
Similar content being viewed by others
References
Drakopanagiotakis F, Polychronopoulos V, Judson MA. Organizing pneumonia. Am J Med Sci. 2008;335:34–9.
Cho SK, Oh IH, Park CK, Bae SC, Sung YK. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rhematol Int. 2010. doi:10.1007/s00296-009-1350-4.
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Cryptogenic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165(2):277–304.
Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136–47.
Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44(6):585–96.
Yoshinouchi T, Ohtsuki Y, Fujita J, Yamadori I, Bandoh S, Ishida T, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int. 2005;26(2):121–5.
Yamamoto M, Ina Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest. 1992;102(1 suppl):21S–5S.
Komagata Y. COP associated with rheumatoid arthritis (in Japanese). Clin Rheumatol. 2008;20:71–5.
Tokuda H. Cryptogenic organizing pneumonia in patients with collagen vascular disease—diagnosis and treatment (in Japanese). Rheumatology. 2009;42:172–82.
Mori S, Cho I, Koga Y, Sugimoto M. A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol. 2008;18(1):60–6.
Lee YH, Kim YR, Ji JD, Shim JJ, Kang KH, Lee JH, et al. A case of BOOP developed during bucillamine treatment for rheumatoid. Korean J Intern Med. 2001;16(1):36–9.
Etanercept: proper use information, vol 9.
Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol. 2009;36(5):898–906.
Hagiwara K, Sato T, Takagi-Kobayashi S, Hasegawa S, Shigihara N, Akiyama O. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol. 2007;34(5):1151–4.
Tournadre A, Ledoux-Eberst J, Poujol D, Dubost JJ, Ristori JM, Soubrier M. Exacerbation of interstitial lung disease during etanercept therapy: two cases. Joint Bone Spine. 2008;75(2):215–8.
Acknowledgment
We wish to express our deep gratitude to Dr. Takeshi Azuma, a visiting professor from St. Marianna University School of Medicine, for his assistance in editing the manuscript.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sakaida, H., Komase, Y. & Takemura, T. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept. Mod Rheumatol 20, 611–616 (2010). https://doi.org/10.1007/s10165-010-0327-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-010-0327-1